Insiders · Profile

Hatzis-Schoch Brent

See Remarks at Black Diamond Therapeutics. Filing since 3 Feb 2020. CIK 0001637054

Company

Date

Role

Action

Shares

Amount

Of holding

BDTX Black Diamond Therapeutics, Inc.

12 May 2021

See Remarks

Sold, plan not stated

4,078

$111.80K

32.7%

BDTX Black Diamond Therapeutics, Inc.

12 Apr 2021

See Remarks

Sold, plan not stated

4,078

$101.95K

32.7%

BDTX Black Diamond Therapeutics, Inc.

12 Mar 2021

See Remarks

Sold, plan not stated

4,078

$107.49K

32.7%

BDTX Black Diamond Therapeutics, Inc.

12 Feb 2021

See Remarks

Sold, plan not stated

4,078

$111.02K

32.7%

BDTX Black Diamond Therapeutics, Inc.

12 Jan 2021

See Remarks

Sold, plan not stated

11,578

$394.04K

58.0%

BDTX Black Diamond Therapeutics, Inc.

14 Dec 2020

See Remarks

Sold, plan not stated

4,078

$142.52K

57.6%

BDTX Black Diamond Therapeutics, Inc.

12 Nov 2020

See Remarks

Sold, plan not stated

4,078

$138.61K

57.6%

BDTX Black Diamond Therapeutics, Inc.

12 Oct 2020

See Remarks

Sold, plan not stated

4,078

$133.33K

57.6%

BDTX Black Diamond Therapeutics, Inc.

14 Sep 2020

See Remarks

Sold, plan not stated

4,078

$126.58K

57.6%

BDTX Black Diamond Therapeutics, Inc.

3 Feb 2020

See Remarks

Bought

3,000

$57.00K

opened

10 decisions on file.